UA106593C2 - Пристрій для пролонгованого введення ліків, який містить полімери на основі поліуретану, та спосіб його виготовлення - Google Patents
Пристрій для пролонгованого введення ліків, який містить полімери на основі поліуретану, та спосіб його виготовленняInfo
- Publication number
- UA106593C2 UA106593C2 UAA201105432A UAA201105432A UA106593C2 UA 106593 C2 UA106593 C2 UA 106593C2 UA A201105432 A UAA201105432 A UA A201105432A UA A201105432 A UAA201105432 A UA A201105432A UA 106593 C2 UA106593 C2 UA 106593C2
- Authority
- UA
- Ukraine
- Prior art keywords
- polyurethane
- basis
- manufacturing
- devices
- long
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 title abstract 2
- 229920002635 polyurethane Polymers 0.000 title abstract 2
- 239000004814 polyurethane Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Prostheses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
Винахід належить до застосування полімеру на основі поліуретану як пристрою для доставки лікарського засобу для доставки біологічно активних сполук з постійною швидкістю протягом тривалого періоду часу і до способів його отримання. Пристрій високо біосумісний та біостійкий і застосовний як імплантат для пацієнтів (людей і тварин) для доставки відповідних біологічно активних речовин до тканин або органів.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/242,497 US7858110B2 (en) | 2003-08-11 | 2008-09-30 | Long term drug delivery devices with polyurethane based polymers and their manufacture |
PCT/US2009/058571 WO2010039641A2 (en) | 2008-09-30 | 2009-09-28 | Long term drug delivery devices with polyurethane-based polymers and their manufacture |
Publications (1)
Publication Number | Publication Date |
---|---|
UA106593C2 true UA106593C2 (uk) | 2014-09-25 |
Family
ID=41594397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201105432A UA106593C2 (uk) | 2008-09-30 | 2009-09-28 | Пристрій для пролонгованого введення ліків, який містить полімери на основі поліуретану, та спосіб його виготовлення |
Country Status (14)
Country | Link |
---|---|
US (5) | US7858110B2 (uk) |
EP (1) | EP2344123A2 (uk) |
JP (2) | JP5677962B2 (uk) |
KR (1) | KR20110063536A (uk) |
CN (1) | CN102202647B (uk) |
AU (1) | AU2009298720C1 (uk) |
BR (1) | BRPI0920824A2 (uk) |
CA (1) | CA2739178C (uk) |
HK (1) | HK1157646A1 (uk) |
IL (1) | IL211954A0 (uk) |
MX (1) | MX2011003299A (uk) |
RU (1) | RU2508089C2 (uk) |
UA (1) | UA106593C2 (uk) |
WO (1) | WO2010039641A2 (uk) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858110B2 (en) | 2003-08-11 | 2010-12-28 | Endo Pharmaceuticals Solutions, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
CA2437639C (en) | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
US20090208540A1 (en) * | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
EP2344125A1 (en) * | 2008-09-30 | 2011-07-20 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of histrelin and methods of use thereof |
US9078900B2 (en) * | 2008-09-30 | 2015-07-14 | Braeburn Pharmaceuticals Bvba Sprl | Implantable device for the delivery of risperidone and methods of use thereof |
US9322103B2 (en) * | 2010-08-06 | 2016-04-26 | Microchips Biotech, Inc. | Biosensor membrane composition, biosensor, and methods for making same |
US9155873B2 (en) | 2011-05-17 | 2015-10-13 | Reprotect, Inc. | Reusable intravaginal delivery device, system, and method |
EP2723357A4 (en) | 2011-06-21 | 2015-04-01 | Bvw Holding Ag | MEDICAL DEVICE COMPRISING BOSWELLIC ACID |
EP2734262B1 (en) * | 2011-07-20 | 2018-02-28 | Patrick F. Kiser | Intravaginal rings for drug delivery |
US8980298B2 (en) | 2011-10-24 | 2015-03-17 | Braeburn Pharmaceuticals Bvba Sprl | Implantable tizanidine compositions and methods of treatment thereof |
CA2853279C (en) | 2011-10-24 | 2021-03-23 | Endo Pharmaceuticals Inc. | Cyclohexylamines |
MX350469B (es) * | 2011-10-24 | 2017-09-07 | Endo Pharmaceuticals Solutions | Composiciones para el suministro de farmacos implantables y metodos para su tratamiento. |
CA2853251A1 (en) * | 2011-10-24 | 2013-05-02 | Endo Pharmaceuticals Solutions Inc. | Implantable rasagiline compositions and methods of treatment thereof |
CA2885941A1 (en) * | 2012-09-28 | 2014-04-03 | Delpor, Inc. | Device and method for sustained release of antipsychotic medications |
AU2013344388A1 (en) * | 2012-11-19 | 2015-07-09 | Braeburn Pharmaceuticals, Inc. | Implantable drug delivery compositions and methods of treatment thereof |
US20160022571A1 (en) * | 2013-03-14 | 2016-01-28 | Braeburn Pharmaceuticals Bvba Sprl | Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof |
SG10201708522SA (en) | 2013-03-15 | 2017-12-28 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
EP3052084A1 (en) * | 2013-09-30 | 2016-08-10 | Universiteit Gent | Polyurethanes as oral drug delivery platform |
BR112016013734A2 (pt) | 2013-12-16 | 2017-08-08 | Asana Biosciences Llc | Composto, composição farmacêutica, kit, e uso de um composto |
US10070686B2 (en) | 2014-08-27 | 2018-09-11 | Nike, Inc. | Soil-shedding article of footwear, components thereof, and methods of making the article |
US10070685B2 (en) | 2014-08-27 | 2018-09-11 | Nike, Inc. | Article of footwear with soil-shedding performance |
TWI706737B (zh) | 2014-08-27 | 2020-10-11 | 荷蘭商耐基創新公司 | 具污垢脫落性能之鞋類製品 |
EP3169175B1 (en) | 2014-08-27 | 2020-06-17 | NIKE Innovate C.V. | Articles of footwear, apparel, and sports equipment with water absorbtion properties |
US10314364B2 (en) | 2014-08-27 | 2019-06-11 | Nike, Inc. | Soil-shedding article of footwear, and method of using the same |
US10339559B2 (en) * | 2014-12-04 | 2019-07-02 | Adobe Inc. | Associating social comments with individual assets used in a campaign |
JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
US10531705B2 (en) | 2016-03-02 | 2020-01-14 | Nike, Inc. | Hydrogel tie layer |
US10675609B2 (en) | 2016-03-02 | 2020-06-09 | Nike, Inc. | Articles with soil-shedding performance |
US10455893B2 (en) | 2016-03-02 | 2019-10-29 | Nike, Inc. | Hydrogel with mesh for soil deflection |
US10362834B2 (en) | 2016-03-02 | 2019-07-30 | Nike, Inc. | Hydrogel connection |
RU2019112740A (ru) | 2016-09-30 | 2020-11-02 | АСАНА БАЙОСАЙЕНСИЗ, ЭлЭлСи | P2x3 и/или p2x2/3 соединения и способы |
TWI700175B (zh) | 2017-08-01 | 2020-08-01 | 荷蘭商耐基創新公司 | 製造用於鞋類物品之外底的組件之方法 |
CN115251518A (zh) | 2017-10-19 | 2022-11-01 | 耐克创新有限合伙公司 | 鞋外底以及用于制造鞋外底的方法 |
US20240082151A1 (en) | 2019-10-07 | 2024-03-14 | Oak Crest Institute Of Science | Orally implantable drug delivery device |
CA3158651A1 (en) | 2019-11-27 | 2021-06-03 | Marc M. Baum | Permeable skin sustained release drug delivery device |
WO2023133517A1 (en) | 2022-01-06 | 2023-07-13 | Oak Crest Institute Of Science | Subdermal implant for sustained drug delivery |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3993073A (en) * | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US3975350A (en) * | 1972-08-02 | 1976-08-17 | Princeton Polymer Laboratories, Incorporated | Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles |
US4136145A (en) | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
US4207890A (en) * | 1977-01-04 | 1980-06-17 | Mcneilab, Inc. | Drug-dispensing device and method |
US4131604A (en) * | 1977-11-23 | 1978-12-26 | Thermo Electron Corporation | Polyurethane elastomer for heart assist devices |
US4207809A (en) | 1978-03-20 | 1980-06-17 | Restaurant Technology, Inc. | Dual reservoir coffee urn |
US4386039A (en) * | 1980-02-11 | 1983-05-31 | Thermo Electron Corporation | Process for forming an optically clear polyurethane lens or cornea |
US4523005A (en) * | 1981-10-30 | 1985-06-11 | Thermedics, Inc. | Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1,4-butane diol |
US4469671A (en) * | 1983-02-22 | 1984-09-04 | Eli Lilly And Company | Contraceptive device |
US4751133A (en) * | 1984-11-13 | 1988-06-14 | Thermedics, Inc. | Medical patches and processes for producing same |
US4673565A (en) * | 1985-05-03 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Pharmaceutical compositions containing hollow fine tubular drug delivery systems |
JPS62223112A (ja) | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
US4743673A (en) * | 1986-12-19 | 1988-05-10 | Tyndale Plains-Hunter, Ltd. | Hydrophilic carboxy polyurethanes |
US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
US5207705A (en) * | 1988-12-08 | 1993-05-04 | Brigham And Women's Hospital | Prosthesis of foam polyurethane and collagen and uses thereof |
US5254662A (en) * | 1990-09-12 | 1993-10-19 | Polymedia Industries, Inc. | Biostable polyurethane products |
US5266325A (en) * | 1990-09-28 | 1993-11-30 | Hydro Med Science Division Of National Patent Development Corp. | Preparation of homogeneous hydrogel copolymers |
AU651654B2 (en) * | 1992-01-14 | 1994-07-28 | Endo Pharmaceuticals Solutions Inc. | Manufacture of water-swellable hydrophilic articles and drug delivery devices |
AU4033893A (en) * | 1992-04-24 | 1993-11-29 | Polymer Technology Group, Inc., The | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
US5629008A (en) * | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
US5354835A (en) * | 1993-07-23 | 1994-10-11 | Saudi Basic Industries Corporation | Desalination process |
US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
DE69603577T2 (de) * | 1995-02-10 | 1999-11-25 | Medtronic Inc | Verfahren und vorrichtung zur verabreichung von analgetika |
US5789411A (en) * | 1995-09-11 | 1998-08-04 | Lance L. Gooberman P. C. | Improvements to rapid opioid detoxification |
PT1238659E (pt) * | 1996-02-02 | 2005-01-31 | Alza Corp | Libertacao sustentada de um agente activo utilizando um sistema implantavel |
FR2752380B1 (fr) | 1996-08-14 | 1998-10-30 | Dow Corning Sa | Procede de fabrication d'un dispositif a liberation controlee |
AUPO251096A0 (en) * | 1996-09-23 | 1996-10-17 | Cardiac Crc Nominees Pty Limited | Polysiloxane-containing polyurethane elastomeric compositions |
US7728049B2 (en) * | 1996-10-08 | 2010-06-01 | Zamore Alan M | Irradiation conversion of thermoplastic to thermoset polymers |
US20010006677A1 (en) | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
MY125849A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
PT1041975E (pt) * | 1997-12-22 | 2003-01-31 | Alza Corp | Membranas de controlo de taxa para dispositivos de fornecimento controlado de drogas |
ES2378675T3 (es) * | 1997-12-30 | 2012-04-16 | Intarcia Therapeutics, Inc | Sistema de suministro de un agente beneficioso con una membrana obturadora |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
CN1434704A (zh) | 1999-12-16 | 2003-08-06 | 三叉技术有限责任公司 | 延长其受体负荷剂量的治疗剂释放的系统和方法 |
US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
AU2001251217A1 (en) * | 2000-03-31 | 2001-10-15 | Norman L. Holy | Compostable, degradable plastic compositions and articles thereof |
CN102871979B (zh) * | 2000-09-01 | 2014-10-22 | 帕尔马亚有限公司 | 缓释药物制剂及其施用方法 |
US6887270B2 (en) * | 2002-02-08 | 2005-05-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
ATE431113T1 (de) * | 2002-05-23 | 2009-05-15 | Active Implants Corp | Gelenk- und zahnimplantate |
US7858110B2 (en) | 2003-08-11 | 2010-12-28 | Endo Pharmaceuticals Solutions, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
US20090208540A1 (en) * | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
CA2437639C (en) | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
US20060110428A1 (en) * | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
GB0417078D0 (en) * | 2004-07-30 | 2004-09-01 | Angiomed Ag | Flexible implant |
CA2575988C (en) | 2004-08-04 | 2014-02-18 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
US7452868B2 (en) * | 2005-03-11 | 2008-11-18 | Indevus Pharmaceuticals, Inc. | Controlled release formulations of octreotide |
US20060257355A1 (en) * | 2005-05-10 | 2006-11-16 | Abiomed, Inc. | Impregnated polymer compositions and devices using them |
US20080004260A1 (en) * | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
WO2008062008A1 (en) * | 2006-11-22 | 2008-05-29 | N.V. Organon | Delivery system for a non-steroidal non-ionized hydrophilic drug |
WO2008070118A1 (en) | 2006-12-05 | 2008-06-12 | Landec Corporation | Drug delivery |
JP5536053B2 (ja) | 2008-06-25 | 2014-07-02 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド. | 離型剤を有するオクトレオチドインプラント |
US9078900B2 (en) | 2008-09-30 | 2015-07-14 | Braeburn Pharmaceuticals Bvba Sprl | Implantable device for the delivery of risperidone and methods of use thereof |
WO2010039717A1 (en) | 2008-09-30 | 2010-04-08 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of octreotide and methods of use thereof |
-
2008
- 2008-09-30 US US12/242,497 patent/US7858110B2/en not_active Expired - Fee Related
-
2009
- 2009-09-28 BR BRPI0920824A patent/BRPI0920824A2/pt not_active Application Discontinuation
- 2009-09-28 CN CN200980142350.9A patent/CN102202647B/zh not_active Expired - Fee Related
- 2009-09-28 CA CA2739178A patent/CA2739178C/en not_active Expired - Fee Related
- 2009-09-28 AU AU2009298720A patent/AU2009298720C1/en not_active Ceased
- 2009-09-28 KR KR1020117008350A patent/KR20110063536A/ko not_active Application Discontinuation
- 2009-09-28 MX MX2011003299A patent/MX2011003299A/es active IP Right Grant
- 2009-09-28 RU RU2011117328/15A patent/RU2508089C2/ru not_active IP Right Cessation
- 2009-09-28 EP EP09737493A patent/EP2344123A2/en not_active Withdrawn
- 2009-09-28 JP JP2011529306A patent/JP5677962B2/ja not_active Expired - Fee Related
- 2009-09-28 UA UAA201105432A patent/UA106593C2/uk unknown
- 2009-09-28 WO PCT/US2009/058571 patent/WO2010039641A2/en active Application Filing
-
2010
- 2010-10-26 US US12/912,655 patent/US8303977B2/en not_active Expired - Fee Related
-
2011
- 2011-03-27 IL IL211954A patent/IL211954A0/en not_active IP Right Cessation
- 2011-11-08 HK HK11112036.8A patent/HK1157646A1/zh not_active IP Right Cessation
-
2012
- 2012-03-09 US US13/416,999 patent/US8460274B2/en not_active Expired - Fee Related
-
2013
- 2013-05-13 US US13/892,946 patent/US8784865B2/en not_active Expired - Fee Related
-
2014
- 2014-06-17 US US14/306,954 patent/US20150105746A1/en not_active Abandoned
- 2014-08-01 JP JP2014157923A patent/JP5897077B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0920824A2 (pt) | 2018-05-29 |
JP5897077B2 (ja) | 2016-03-30 |
CN102202647A (zh) | 2011-09-28 |
CA2739178A1 (en) | 2010-04-08 |
US20120231061A1 (en) | 2012-09-13 |
JP2014224137A (ja) | 2014-12-04 |
RU2508089C2 (ru) | 2014-02-27 |
US8303977B2 (en) | 2012-11-06 |
RU2011117328A (ru) | 2012-11-10 |
AU2009298720A1 (en) | 2010-04-08 |
HK1157646A1 (zh) | 2012-07-06 |
JP5677962B2 (ja) | 2015-02-25 |
CN102202647B (zh) | 2015-11-25 |
EP2344123A2 (en) | 2011-07-20 |
KR20110063536A (ko) | 2011-06-10 |
US20150105746A1 (en) | 2015-04-16 |
WO2010039641A3 (en) | 2010-07-29 |
AU2009298720C1 (en) | 2015-12-17 |
US20110184376A1 (en) | 2011-07-28 |
CA2739178C (en) | 2016-09-06 |
AU2009298720B2 (en) | 2015-07-16 |
MX2011003299A (es) | 2011-06-09 |
US20140012222A1 (en) | 2014-01-09 |
JP2012504138A (ja) | 2012-02-16 |
WO2010039641A2 (en) | 2010-04-08 |
US7858110B2 (en) | 2010-12-28 |
IL211954A0 (en) | 2011-06-30 |
US20090098182A1 (en) | 2009-04-16 |
US8460274B2 (en) | 2013-06-11 |
US8784865B2 (en) | 2014-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA106593C2 (uk) | Пристрій для пролонгованого введення ліків, який містить полімери на основі поліуретану, та спосіб його виготовлення | |
UA105502C2 (uk) | Імплантований пристрій для введення октреатиду та спосіб його використання | |
ATE421316T1 (de) | Herstellung von langzeit- arzneimittelabgabevorrichtungen mit polymeren auf polyurethanbasis | |
CY1120964T1 (el) | Ετερογενη εμφυτευσιμα προϊοντα για χορηγηση φαρμακων | |
WO2011127064A3 (en) | Sustained-release reservoir implants for intracameral drug delivery | |
BRPI0904961A2 (pt) | Dispositivo médico implantável, depósito de fármaco e método de administrar um agente biologicamente ativo e clonidina ou um derivado da mesma a um tecido e de produzir um depósito de fármaco | |
WO2010025378A3 (en) | Drug delivery implants | |
WO2009036014A3 (en) | Medical devices with triggerable bioadhesive material | |
WO2007090079A3 (en) | Therapeutic agent eluding implant with percutaneous supply | |
WO2013078257A3 (en) | Implantable solid-liquig drug delivery apparatus, formulations, and methods of use | |
EP2392363A3 (en) | Drug coated expandable devices | |
EA201170297A1 (ru) | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей | |
DE602005018178D1 (de) | Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen | |
BRPI0820800A2 (pt) | Dispositivo médico implantável para liberação controlada de droga, e, métodos para administração de uma droga na bexiga de um paciente e para tratar a bexiga em um paciente | |
EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
MX362908B (es) | Implantes que contienen fármacos y métodos de uso de los mismos. | |
MX2019014942A (es) | Dispositivos de administracion de farmacos bioerosionables. | |
WO2010034016A3 (en) | Diaphragm drug pump | |
WO2014006506A3 (en) | Direct deployment system and method | |
WO2012109535A3 (en) | Amino acid derivatives and absorbable polymers therefrom | |
EP2246076A3 (en) | Dual drug stent | |
BR112015011294A2 (pt) | nanopartículas com polímero biodegradável e biocompatível plga carregadas com o fármaco de uso humano pentoxifilina | |
EP2745856A3 (en) | Bioactive Compositions, Bioactive Eluting Devices and Methods of Use Thereof | |
DE602007007671D1 (de) | Medizinische Vorrichtungen zur lokalen Arzneimittelabgabe | |
WO2009006390A3 (en) | Drug-eluting staples prosthesis |